← Open Payments lookup

LATIA BUTTS: Open Payments

NPI 1164731931 · GRENADA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,229 in 107 payments from 28 companies in 2025. Trend: 2023 $2,075 · 2024 $1,878 · 2025 $2,229

Food & beverage: $2,213Education: $16
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.13$221
Merck Sharp & Dohme LLC8$207
Novartis Pharmaceuticals Corporation9$182
Takeda Pharmaceuticals U.S.A., Inc.9$180
Gilead Sciences, Inc.6$179
Lilly USA, LLC6$148
Celgene Corporation7$145
Daiichi Sankyo Inc.6$144
PFIZER INC.7$99
ARRAY BIOPHARMA INC4$77

Products named: KEYTRUDA, Trodelvy, REBLOZYL, Enhertu, OPDIVO, VERZENIO, BRAFTOVI, SCEMBLIX.

Industry payments across MS — which companies pay providers there.